Newly developed endovascular catheter shows unprecedented ability to treat pulmonary artery obstruction
Researchers identify molecular mechanisms leading to Zika-associated microcephaly
19 September 2022How can infants learn about sounds in their native language?
19 September 2022Newly developed endovascular catheter shows unprecedented ability to treat pulmonary artery obstruction
A device known as the BASHIR Endovascular Catheter (THROMBOLEX, Inc.) significantly reduces the size of blood clots lodged in the pulmonary arteries, leading to improvement in heart function in patients with pulmonary embolism, researchers from the Lewis Katz School of Medicine at Temple University announced in a Late-Breaking Innovation session at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) conference in Boston. The breakthrough is described in detail in a report simultaneously published online in the JACC: Cardiovascular Interventions.
